Edwards Lifesciences
1,212 hedge funds and large institutions have $34.2B invested in Edwards Lifesciences in 2023 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 427 increasing their positions, 463 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $46.5B → $34.2B (-$12.3B)
29% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 153
67% less funds holding in top 10
Funds holding in top 10: 18 → 6 (-12)
Holders
1,212
Holding in Top 10
6
Calls
$292M
Puts
$154M
Top Buyers
| 1 | +$224M | |
| 2 | +$198M | |
| 3 | +$171M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$154M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$96.3M |
Top Sellers
| 1 | -$488M | |
| 2 | -$192M | |
| 3 | -$172M | |
| 4 |
Holocene Advisors
New York
|
-$131M |
| 5 |
Amundi
Paris,
France
|
-$106M |